Name: Aqneursa (levacetylleucine) in Ataxia-telangiectasia: American hospital formulary service (AHFS), or other drug classification
Published: 2026-10-02T18:22:10-04:00

Product information and disease description Product description Product information

American hospital formulary service (AHFS), or other drug classification

4 evidence topics · 4 sources

AHFS classification

“Drug class: Other Miscellaneous Therapeutic Agents” (opens the source at this quote in a new tab)

ATC classification: WHO index

ATC level	Code	Name
Anatomical main group	“N”	“NERVOUS SYSTEM”
Therapeutic subgroup	“N07”	“OTHER NERVOUS SYSTEM DRUGS”
Chemical subgroup	“N07XX”	“Other nervous system drugs”
Chemical substance	“N07XX27”	“levacetylleucine”

ATC classification: European Medicines Agency record

Field	Quoted record
Anatomical therapeutic chemical (ATC) code	“N07XX27”
Pharmacotherapeutic group	“Other nervous system drugs”

FDA pharmacologic class indexing

Field	Quoted record
Product NDC	“83853-101”
Pharmacologic class	“Bile Salt Export Pump Inhibitors [MoA]”
Pharmacologic class	“Breast Cancer Resistance Protein Inhibitors [MoA]”
Pharmacologic class	“Organic Anion Transporter 1 Inhibitors [MoA]”
Pharmacologic class	“Organic Anion Transporter 3 Inhibitors [MoA]”
Pharmacologic class	“P-Glycoprotein Inhibitors [MoA]”